Smoking topography and outcome expectancies among individuals with schizotypy

Psychiatry Research

Volumn 205, Issue 3, 2013, Pages 205-212

  Stewart, Diana W ^a   Vinci, Christine ^b   Adams, Claire E ^a   Cohen, Alex S ^b   Copeland, Amy L ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Cigarette smoking; Schizophrenia; Schizotypy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPECTANCY; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; SCHIZOTYPAL PERSONALITY DISORDER; SENSORIMOTOR FUNCTION; SMOKING; SOCIAL BEHAVIOR; STIMULATION; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; TOPOGRAPHY;

FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; YOUNG ADULT;

EID: 84873524471     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.11.032     Document Type: Article

References (84)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin 1998, 24:189-202.
2. Allan L.M., Williams J.H., Wellman N.A., Tonin J., Taylor E., Feldon J., Rawlins J.N.P. Effects of tobacco smoking, schizotypy, and number of pre-exposures on latent inhibition in healthy subjects. Personality and Individual Differences 1995, 19:893-902.
3. American Cancer Society, 2011. Cancer Facts & Figures 2011. American Cancer Society, Atlanta, GA. Available from: (accessed 1.11.11). http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011.
4. Aubin H.-J., Rollema H., Svensson T.H., Winterer G. Smoking, quitting, and psychiatric disease: a review. Neuroscience and Biobehavioral Reviews 2012, 36:271-284.
5. Barr A.M., Procyshyn R.M., Hui P., Johnson J.L., Honer W.G. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophrenia Research 2008, 100:252-260.
6. Baxter D.N. The mortality experience of individuals on the Salford psychiatric case register. British Journal of Psychiatry 1996, 168:772-779.
7. Benowitz N.L. Tobacco use and cessation. Primary Care: Clinics in Office Practice 1999, 26:611-631.
8. Beratis S., Katrivanou A., Gourzis P. Factors affecting smoking in schizophrenia. Comprehensive Psychiatry 2001, 42:393-402.
9. Blanchard J.J., Gangestad S.W., Brown S.A., Horan W.P. Hedonic capacity and schizotypy revisited: a taxometric analysis of social anhedonia. Journal of Abnormal Psychology 2000, 109:87-95.
10. Brandon T.H., Baker T.B. The Smoking Consequences Questionnaire: the subjective expected utility of smoking in college students. Psychological Assessment 1991, 3:484-491.
11. Brandon T.H., Juliano L.M., Copeland A.L. Expectancies for tobacco smoking. How Expectancies Shape Experience 1999, American Psychological Association, Washington DC, 263-299. I. Kirsch (Ed.).
12. Buckley T.C., Kamholz B.W., Mozley S.L., Gulliver S.B., Holohan D.R., Helstrom A.W., Walsh K., Morissette S.B., Kassel J.D. A psychometric evaluation of the Smoking Consequences Questionnaire-Adult in smokers with psychiatric conditions. Nicotine and Tobacco Research 2005, 7:739-745.
13. Chapman L.J., Chapman J.P., Raulin M.L., Edell W.S. Schizotypy and thought disorder as a high-risk approach to schizophrenia. Cognitive Deficits in the Development of Mental Illness 1978, Brunner/Mazel, New York, 351-360. G. Serban (Ed.).
14. Claridge G.S. Origins of Mental Illness 1985, Blackwell, Oxford.
15. Cohen A.S., Matthews R., Najolia G.M., Brown L.A. Toward a more psychometrically sound brief measure of schizotypal traits: introducing the SPQ-Brief Revised. Journal of Personality Disorders 2010, 24:516-537.
16. Cohen A.S., Buckner J., Najolia G., Stewart D.W. Cannabis and psychometrically-defined schizotypy: use, problems, and treatment considerations. Journal of Psychiatry Research 2011, 45:548-554.
17. Cohen A.S., Morrison S., Brown L.A., Minor K.S. Towards a cognitive resource limitations model of diminished expressivity in schizotypy. Journal of Abnormal Psychology 2012, 121:109-118.
18. Copeland A.L., Brandon T.H., Quinn E.P. The Smoking Consequences Questionnaire-Adult: measurement of smoking outcome expectancies of experienced smokers. Psychological Assessment 1995, 7:484-494.
19. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 1998, 155:1490.
20. de Leon J. Smoking and vulnerability for schizophrenia. Schizophrenia Bulletin 1996, 22:405-409.
21. de Leon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. American Journal of Psychiatry 1995, 152:453-455.
22. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophrenia Research 2002, 56:47-54.
23. de Leon J., Becoña E., Gupegui M., Gonzalez-Pinto A., Diaz F.J. The association between high nicotine dependence and severe mental illness may be consistent across countries. Journal of Clinical Psychiatry 2002, 63:812-816.
24. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005, 76:135-157.
25. Derogatis, L.R., 1975. Brief Symptom Inventory. Clinical Psychometric Research, Baltimore, MD.
26. Derogatis L.R., Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychological Medicine 1983, 13:595-605.
27. Esterberg M.L., Compton M.T. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Social Science and Medicine 2005, 61:293-303.
28. Esterberg M.L., Jones E.M., Compton M.T., Walker E.F. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophrenia Research 2007, 97:6-13.
29. Fanous A., Gardner C., Walsh D., Kendler K.S. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in non-psychiatric relatives. Archives of General Psychiatry 2001, 58:669-673.
30. Fidler J.A., West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine and Tobacco Research 2009, 11:1182-1188.
31. Forchuk C., Norman R., Malla A., Martin M.-L., McLean T., Cheng S., Diaz K., McIntosh E., Rickwood A., Vos S., Gibney C. Schizophrenia and the motivation for smoking. Perspectives in Psychiatric Care 2002, 38:41-49.
32. Galazyn M., Steinberg M.L., Gandhi K.K., Williams J.M., Piper M. Reasons for smoking among individuals with schizophrenia. Schizophrenia Research 2010, 122:268-269.
33. George T.P., Termaine A., Sacco K.A., Allen T.M., Reutenauer E., Vessicchio J.C. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotine receptor mechanisms. Schizophrenia Research 2006, 87:307-315.
34. Glassman A.H. Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry 1993, 150:546-553.
35. Glynn S.M., Sussman S. Why patients smoke. Hospital Community Psychiatry 1990, 41:1027-1028.
36. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
37. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 2005, 150:1115-1121.
38. Hitsman B., Spring B., Wolf W., Pingitore R., Crayton J.W., Hedeker D. Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls. Neuropsychopharmacology 2005, 30:640-648.
39. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 1986, 143:993-997.
40. Kelly C., McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 1999, 156:1751-1757.
41. Larrison A.L., Briand K.A., Sereno A.B. Nicotine, caffeine, alcohol, and schizotypy. Personality and Individual Differences 1999, 27:101-108.
42. Lasser K., Boyd J.W., Wollhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association 2000, 284:2602-2610.
43. Lee E.M., Malson J.L., Waters A.J., Moolchan E.T., Pickworth W.B. Smoking topography: reliability and validity in dependent smokers. Nicotine and Tobacco Research 2003, 5:673-679.
44. Lenzenweger M.F. Schizotaxia, schizotypy and schizophrenia: Paul E. Meehl's blueprint for experimental psychopathology and the genetics of schizophrenia. Journal of Abnormal Psychology 2006, 115:195-200.
45. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Research 1992, 8:93-102.
46. McEvoy J., Brown S. Smoking in first-episode patients with schizophrenia. American Journal of Psychiatry 1999, 156:1120-1121.
47. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.L. Actual causes of death in the United States, 2000. Journal of the American Medical Association 2004, 291:1238-1245.
48. Meehl P.E. Schizotaxia, schizotypy, schizophrenia. American Psychologist 1962, 17:827-838.
49. Meehl P.E. Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. Journal of Personality Disorders 1990, 4:1-99.
50. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry 1997, 42:1-5.
51. Piper M.E., McCarthy D.E., Bolt D.M., Smith S.S., Lerman C., Benowitz N., Fiore M.C., Baker T.C. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine and Tobacco Research 2008, 10:1009-1020.
52. Piper M.E., Piasecki T.M., Federman E.B., Bolt D.M., Smith S.S., Fiore M.C., Baker T.B. A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). Journal of Consulting and Clinical Psychology 2004, 72:139-154.
53. Raine A. The SPQ: a scale for the assessment of Schizotypal Personality based on DSM-III-R criteria. Schizophrenia Bulletin 1991, 17:555-564.
54. Rash C.J., Copeland A.L. The Brief Smoking Consequences Questionnaire-Adult (BSCQ-A): development of a short form of the SCQ-A. Nicotine and Tobacco Research 2008, 10:1633-1643.
55. Rawlings D., Williams B., Haslam N., Claridge G. Taxometric analysis supports a dimensional latent structure for schizotypy. Personality and Individual Differences 2008, 44:1640-1651.
56. Riala K., Hakko H., Isohanni M., Pouta A., Räsänen P. Is initiation of smoking associated with the prodromal phase of schizophrenia?. Journal of Psychiatric Neuroscience 2004, 30:26-32.
57. Rigotti N.A., Lee J.E., Weschler H. US college students' use of tobacco products: results of a national survey. Journal of the American Medical Association 2000, 284:699-705.
58. Ríos-Bedoya C.F., Snedecor S.M., Pomerleau C.S., Pomerleau O.F. Association of withdrawal features with nicotine dependence as measured by the Fagerström Test for Nicotine Dependence (FTND). Addictive Behaviors 2008, 33:1086-1089.
59. Schultz S.K., Andreasen N.C. Schizophrenia. Lancet 1999, 353:1425-1430.
60. Schuster C.R., Johanson C.E. The use of animal models for the study of drug abuse. Research Advances in Alcohol and Drug Problems 1974, 1:1-31.
61. Siever L.J., Kalus O.F., Keefe R.S. The boundaries of schizophrenia. Psychiatric Clinics of North America 1993, 16:217-244.
62. Smith, S.S., Piper, M.E., Fiore, M.C., Baker, T.B., 2007. Subscale consolidation and item reduction of the 68-item Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). Poster presented at the 13th annual meeting of the Society for Research on Nicotine and Tobacco, Austin, TX.
63. Society for Nicotine and Tobacco subcommittee on biochemical verification Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research 2002, 4:149-159.
64. Solty H., Crockford D., White W.D., Currie S. Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients. Canadian Journal of Psychiatry 2009, 54:36-45.
65. Stewart D.W., Cohen A.S., Copeland A.L. Smoking across the schizotypy spectrum. Psychiatry Research 2010, 179:113-115.
66. Strand J.E., Nybäck H. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls. European Psychiatry 2005, 20:50-54.
67. Sutfin E.L., Reboussin B.A., McCoy T.P., Wolfson M. Are college student smokers really a homogenous group? A latent class analysis of college student smokers. Nicotine and Tobacco Research 2009, 1:444-454.
68. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2007, Pearson, Boston. 5th ed.
69. Tscheslavski G.V. Effects of tobacco smoking and schizotypal personality on spectral contents of spontaneous EEG. International Journal of Psychophysiology 2008, 70:88-93.
70. Tidey J.W., Rohsenow D.J. Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder, and non-psychiatric controls. Schizophrenia Research 2009, 115:310-316.
71. Tidey J.W., Rohsenow D.J., Kaplan G.B., Swift R.M. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug and Alcohol Dependence 2005, 80:259-265.
72. Tidey J.W., Rohsenow D.J., Kaplan G.B., Swift R.M., Adolfo A.B. Effects of smoking abstinence, smoking cues, and nicotine replacement, in smokers with schizophrenia and controls. Nicotine and Tobacco Research 2008, 10:1047-1056.
73. Ucok A., Polat A., Bozkurt O., Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry and Clinical Neurosciences 2004, 58:434-437.
74. Walker E.F., Gale S. Neurodevelopmental processes in schizophrenia and schizotypal personality disorder. Schizotypal Personality 1995, Cambridge University Press, New York, pp. 56-75. A. Raine, T. Lencz, S.A. Mednick (Eds.).
75. Weinberger A.H., Sacco K.A., Creeden C.L., Vessicchio J.C., Jatlow P.I., George T.P. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophrenia Research 2007, 91:217-225.
76. Wiles N.J., Zammit S., Bebbington P., Singleton N., Meltzer H., Lewis G. Self-reported psychotic symptoms in the general population. Results from the longitudinal study of the British National Psychiatric Morbidity Study. British Journal of Psychiatry 2006, 188:519-526.
77. Williams, J.M., Gandhi, K.K., Karavidas, M., Foulds, J., 2006. More puffs and shorter interpuff interval in smokers with schizophrenia using CReSSmicro® Topography Device. Paper presented at the 12th annual meeting of the Society for Research on Nicotine and Tobacco, Orlando, FL.
78. Williams J.M., Gandhi K.K., Lu S.-E., Kumar S., Shen J., Foulds J., Kipen H., Benowitz N.L. Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine and Tobacco Research 2010, 12:855-859.
79. Williams J.M., Gandhi K.K., Lu S.-E., Kumar S., Steinberg M.L., Cottler B., Benowitz N.L. Shorter interpuff interval is associated with higher nicotine in smokers with schizophrenia. Drug and Alcohol Dependence 2011, 118:313-319.
80. Williams J.M., Gandhi K.K., Steinberg M.L., Foulds J., Ziedonis D.M., Benowitz N.L. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine and Tobacco Research 2007, 9:873-881.
81. Williams J.M., Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors 2004, 29:1067-1083.
82. Williams J.M., Ziedonis D.M., Abanyie F., Steinberg M.L., Foulds J., Benowitz N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic affect. Schizophrenia Research 2005, 79:323-335.
83. Workgroup on Substance Use Disorders, American Psychiatric Association Steering Committee on Practice Guidelines, 2006. Treatment of patients with substance use disorders. 2nd ed. American Psychiatric Association. American Journal of Psychiatry 163, 5-82.
84. Zacny J.P., Stitzer M.L., Brown F.J., Yingling J.E., Griffiths R.R. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. Journal of Pharmacological Experimental Therapy 1987, 240:554-564.